Atara Biotherapeutics, Inc. ( ATRA) - Key Metrics
ATRA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.13 | -$0.27 | -$0.45 | -$0.45 |
| 2025Q3 | $0.25 | -$0.32 | -$0.72 | -$0.72 |
| 2025Q2 | $1.44 | $0.20 | -$0.60 | -$0.60 |
| 2025Q1 | $9.12 | $3.53 | -$2.61 | -$2.61 |
ATRA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -16.66 |
| 2025Q3 | ? | -11.29 |
| 2025Q2 | ? | 9.86 |
| 2025Q1 | ? | 0.42 |
ATRA
Price: $10.07
52 week price:
Earnings Per Share: -1.22 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 783100
Ebitda: -31.4 millionMarket Capitalization: 89.4 million